Electronic Palpation Device Is Adjunct to Manual Breast Exam. Oncology News International. 1999(2).
FDA-cleared breast self-examination pad now available nationwide. Primary Care and Cancer. 1999; 19: 42.
Final Report of the Technology Transfer Workshop on Breast Cancer Detection, Diagnosis, and Treatment. Washington, D.C., USA. May 1-2, 1997. Acad Radiol 1998 Nov;5 Suppl 3: S465-501.
The Cancer Letter. 2000; 15(2).
The Cancer Letter. 2000; 15(3).
Using “Radar” to detect breast cancer. Microwave News. 2000; 8.
[letter]. J Health Care Poor Underserved. 1999; 10: 269-80., , , . Utilization of early detection services: a recruitment and screening program for African American women
Ann NY Acad Sci. 1997; 820: 248-70; discussion 271., , . Advances in optical imaging of biomedical media.
[see comments]. Nature. 2000; 403: 503-11., , , et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Breast Cancer Res Treat. 1999; 55: 243-58., , , , . A study on the cost effectiveness of sestamibi scintimammography for screening women with dense breasts for breast cancer.
Philadelphia: Lippincott Williams & Wilkins; 2000: 355-366. Harris JR., ; Biological features of human premalignant breast disease. In: Diseases of the Breast.
2000.. Cancer Facts and Figures;
Adopted on February 20, 1996. J Clin Oncol. 1996; 14: 1730-6; discussion 1737-40.. Statement on genetic testing for cancer susceptibility,
Breast Cancer Res Treat. 1996; 39: 119-35., , . Transgenic mouse models of breast cancer.
Biomedical Thermology. 1995; 15: 135-9.. Mechanism of hyperthermia of the cancerous breast.
Infrared Technology and Applications XXV: April 5, 1999-April 9, 1999; Orlando, FL. Part of the SPIE Conference on Infared Technology and Applications XXV., , , . Clinical Applications of DAT using a QWIP FPA camera.
Thermology International. 1999; 127-33., , . Objective identification of cancerous breasts by dynamic area telethermometry (DAT).
[news]. J Natl Cancer Inst. 1994; 86: 1580-2.. Issues raised on availability of breast cancer materials for research
Br J Cancer. 1997; 76: 1546-9., , , et al. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy.
Phys Med Biol. 1998a; 43: 2845-52., , , et al. Low-dose phase contrast x-ray medical imaging.
Radiology. 1998b; 208: 709-15., , , et al. Mammography of a phantom and breast tissue with synchrotron radiation and a linear-array silicon detector.
Radiology. 2000; 215: 286-93., , , et al. Mammography with synchrotron radiation: phase-detection techniques.
[editorial]. J Gen Intern Med. 1995; 10: 295-7.. To screen or not to screen: What is the question?
1999.The Clinical Assessment of Electronic Palpation Technology: A New Approach for the Early Detection and Monitoring of Breast Lesions.
Acad Radiol. 1998; 5 Suppl 2: S389-91.. Technology assessment and reimbursement for future new imaging technologies.
Ann Intern Med. 1994; 120: 326-34.. The Canadian National Breast Screening Study: a perspective on criticisms.
Cancer. 1990; 65: 1663-9., . Women's attitudes to screening after participation in the National Breast Screening Study. A questionnaire survey.
[see comments]. JAMA. 1990; 264: 235-40., . The case for reassessment of health care technology. Once is not enough
JAMA. 1999; 282: 1270-80., , . Does this patient have breast cancer? The screening clinical breast examination: should it be done? How?
Adv Cancer Res. 1998; 72: 141-96., , , , . Alterations in DNA methylation: a fundamental aspect of neoplasia.
Arch Intern Med. 1996; 156: 209-13., , . Variability in the interpretation of screening mammograms by US radiologists. Findings from a national sample.
Acad Radiol. 1996; 3: 891-7., , . Effect of human variability on independent double reading in screening mammography.
Cancer Res. 1993; 53: 2644-54., . Culture of normal and malignant primary human mammary epithelial cells in a physiological manner simulates in vivo growth patterns and allows discrimination of cell type.
[see comments]. AJR Am J Roentgenol. 1999; 173: 1161-7.. The missed breast cancer: perceptions and realities
[see comments]. J Natl Cancer Inst. 1998; 90: 1431-9.. Benefits and risks of screening mammography for women in their forties: a statistical appraisal
Hum Mutat. 1998; 12: 226-37., , , . Mutations of the human E-cadherin (CDH1) gene.
Mor Mortal Wkly Rep CDC Surveill Summ. 1999; 48: 1-22., , . Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)—Behavioral Risk Factor Surveillance System.
BMJ. 2000; 321: 665-669., , , , . Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality.
1997. Volume 12.. Scintimammography;
Endoscopy. 1996; 28: 372-80.. Tissue spectroscopy for gastrointestinal diseases.
Acta Radiol. 1997; 38: 489-96., , , . Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions.
Acta Oncol. 1992; 31: 151-5.. Role of genetic factors in breast cancer susceptibility.
Am J Roentgenol. 1990; 155: 43-7., , , , . Optical spectroscopy (INVOS) is unreliable in detecting breast cancer.
Era of Hope Department of Defense Breast Cancer Program Meeting: June, 2000., , , , . Optical biopsy for the diagnosis of breast tumors.
Am J Manag Care. 1998; 4 Spec No:SP139-50., , , . Role of technology assessment in health benefits coverage for medical devices.
[see comments] [published erratum appears in N Engl J Med 2000 Jul 27;343(4): 308]. N Engl J Med. 2000; 342: 525-33., , , et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer
1998.. Charting The Course: Priorities For Breast Cancer Research: Breast Cancer Progress Review Group;
N Engl J Med. 1996; 335: 1963-7., , . Relation between negligent adverse events and the outcomes of medical-malpractice litigation
Diagn Imaging (San Franc). 2000; 22.. Small change for big medicine: The crisis in breast imaging services.
Non-Invasive System for Breast Cancer Detection5704355. 1998 Jan 6., inventor;
Am J Hum Genet. 2000; 66: 494-500., , , et al. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.
JAMA. 1999; 281: 347-53., . Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing.
Breast Cancer Res Treat. 1993; 25: 113-8., . Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature.
AJR Am J Roentgenol. 1995; 165: 1373-7., , , . Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures.
Radiology. 1995; 195: 239-44., , , et al. Mammography with synchrotron radiation.
Arch Pathol Lab Med. 1998; 122: 871-4., . Specimen banks for cancer prognostic factor research.
Cancer Genetics Studies Consortium [see comments]. JAMA. 1997; 277: 997-1003., , , et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2.
Ann Intern Med. 1999; 131: 1-6., , , . Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization.
Radiographics. 1998; 18: 1587-98., , , et al. Analysis of mammographic density and breast cancer risk from digitized mammograms.
The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer, [see comments]. . 1998; 158 Suppl 3: S3-8.. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected.
Ultrasound Med Biol. 1998; 24: 945-52., , , et al. 3-D color Doppler image quantification of breast masses.
MMWR Morb Weekly Report. 1998; 47: 853-6.. Use of cervical and breast cancer screening among women with and without functional limitations—United States, 1994-1995.
Radiology. 1999; 212: 817-27., , , et al. Improvement of radiologists' characterization of mammographic masses by using computer-aided diagnosis: an ROC study.
Ann N Y Acad Sci. 1998; 838: 29-45.. Near-infrared images using continuous, phase-modulated, and pulsed light with quantitation of blood and blood oxygenation.
3d, . Specific value of computed tomographic breast scanner (CT/M) in diagnosis of breast diseases. Radiology. 1979; 132: 647-52., , ,
Cancer. 1980; 46: 939-46., , , et al. Computed tomography in detection and diagnosis of breast cancer.
Radiology. 1977; 124: 827-9., , , et al. Computed tomography of the breast. A preliminary report.
Indian J Biochem Biophys. 1984; 21: 76-9., , , . Dielectric properties of normal & malignant human breast tissues at radiowave & microwave frequencies.
Cancer Res. 1998; 58: 1376-9., , , , . The role of ataxia-telangiectasia heterozygotes in familial breast cancer.
Cancer Treat Rev. 2000; 26: 91-102., , . Tumour marker measurements in the diagnosis and monitoring of breast cancer.
J Natl Cancer Inst. 2000; 92: 1657-66., , , et al. Predicting the cumulative risk of false-positive mammograms.
Epithelial Cell Biol. 1994; 3: 38-46., , , . An immunomagnetic separation method using superparamagnetic (MACS) beads for large-scale purification of human mammary luminal and myoepithelial cells.
Scientific American. 1994; 271: 46-53.SQUIDS.
Cancer Treat Rev. 2000; 26: 291-302., , . Breast cancer risk following irradiation for Hodgkin's disease.
1999.High Through Put Expression Profiling With Atlas;
Ann Oncol. 1995; 6 Suppl 2: 11-21.. The natural history of operable breast cancer after primary treatment.
J Cancer Educ. 1991; 6: 83-92.. Practice and effectiveness of breast self examination: a selective review of the literature (1977-1989).
N Engl J Med. 2000; 342: 1887-92., , . Randomized, controlled trials, observational studies, and the hierarchy of research design.
Nat Genet. 1997; 17: 423-30., , , et al. Tumorigenesis and a DNA repair defect in mice with a truncating BRCA2 mutation.
Am J Hum Genet. 1997; 61: 259-66., . The regulation of splice-site selection, and its role in human disease.
Science. 1999; 286: 1162-6., , , . Requirement of ATM-dependent phosphorylation of brcal in the DNA damage response to double-strand breaks.
Nat Genet. 2000; 24: 132-8., , , et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
Ann Oncol. 1994; 5: 305-11., . Clinical prognostic significance of tumour angiogenesis.
Surg Gynecol Obstet. 1929; 48: 721-9.. Transillumination as an aid in the diagnosis of breast lesions.
Lancet. 1998; 352: 359-63., , , et al. Electropotential measurements as a new diagnostic modality for breast cancer.
J Natl Cancer Inst. 2000; 92: 452-6., , , et al. Participation in the cooperative family registry for breast cancer studies: issues of informed consent.
Am J Pathol. 1996; 148: 313-9., , , , . MCF10AT: a model for the evolution of cancer from proliferative breast disease.
Radiology. 1996; 201: 433-7., , , . Mobile mammography: results of a national survey.
Q J Nucl Med. 1999; 43: 125-31., , . Clinical imaging of multidrug resistance in cancer.
et al., Genetic Information and the Workplace: (January 20, 1998).
Ann Intern Med. 1990; 113: 147-54., . A clinician's guide to cost-effectiveness analysis.
Breast Cancer. 1997; 4: 228-233., , , . Computer-Aided Diagnosis of Breast Cancer on Mammograms.
Am J Roentgenol. 1995; 165: 281-4., , , . Selective use of image-guided large-core needle biopsy of the breast: accuracy and cost-effectiveness.
Br J Cancer. 1997; 76: 377-81., , , , . Sensitivity, specificity and predictive values of breast imaging in the detection of cancer.
Cancer Epidemiol Biomarkers Prev. 1999; 8: 843-54., , , , , . A systematic review of genetic polymorphisms and breast cancer risk.
1996.. Cost and Benefit Analysis of Regulation Under the Mammograpgy Quality Standards Act of 1992 Preliminary Report;
The Breast Cancer Linkage Consortium. Am J Hum Genet. 1993; 52: 678-701., , , . Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families.
Del Med J. 1999; 71: 377-82., . Current imaging modalities for the diagnosis of breast cancer.
J Clin Oncol. 2000; 18: 1980-95., , , . Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.
Proc Natl Acad Sci U S A. 1998; 95: 14863-8., , , . Cluster analysis and display of genomewide expression patterns.
JAMA. 1999; 282: 1865-9.. Ten lessons for evidence-based technology assessment.
Diagn Imaging (San Franc). 2000; 22(4): 31-3, 69.. Shortage of qualified breast imagers could lead to crisis.
N Engl J Med. 1998a; 338: 1089-96., , , , , . Ten-year risk of false positive screening mammograms and clinical breast examinations.
J Womens Health. 1998b; 7: 443-9., , . Does diagnostic accuracy in mammography depend on radiologists' experience?
N Engl J Med. 1994; 331: 1493-9., , , , . Variability in radiologists' interpretations of mammograms.
Science. 1996; 274: 998-1001., , , et al. Laser capture microdissection.
Cancer Res. 1978; 38: 4327-39., . Human breast carcinoma cells in continuous culture: a review.
J Natl Cancer Inst Monogr. 1997: 151-6., . Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma.
JAMA. 1996; 275: 913-8., , , , . Incidence of and treatment for ductal carcinoma in situ of the breast.
In press., , , et al. Prevention Clinical Trial Models Utilizing Breast Intraepitheial Neoplasia as an Endpoint.
Surg Oncol Clin N Am. 1997; 6: 285-99., . The role of stereotactic biopsy in abnormal mammograms.
Seminars In Breast Disease. 1999; 2: 74-88., , , . Magnetic Resonance Imaging of Breast Tumors.
Radiol Clin North Am. 2000; 38: 825-42., . An introduction to economic issues in breast imaging.
Eur J Radiol. 1997; 24: 33-8., , , et al. Electropotential evaluation as a new technique for diagnosing breast lesions.
IEEE Microwave and Guided Wave Letters. 1999; 9: 470-2., . Microwave System for Breast Tumor Detection.
1999; 64(80): 22619-25.. Medicare Program: Procedures for Making National Coverage Decisions.
2000; 65(95): 31124-29.. Medicare Program: Criteria for Making Coverage Decisions.
2000a.. SBI News, President's Message: Behind the Scenes of an SBI Epic Production;
1999a; 2: 3-16.. Principles and practice of breast imaging, Seminars in breast disease.
Radiol Clin North Am. 2000b; 38: 843-52.. Economic challenges in breast imaging. A survivor's guide to success.
1999b.. President's Message: SBI Residency Training Curriculum;
Semin Nucl Med. 1999c; 29: 3-15.. Role and evaluation of mammography and other imaging methods for breast cancer detection, diagnosis, and staging.
J Natl Cancer Inst Monogr. 1997: 119-24., . Radiation risk from screening mammography of women aged 40-49 years.
Radiology. 1977; 122: 123-7., , , et al. Thermography, mammography, and clinical examination in breast cancer screening. Review of 16,000 studies.
J Natl Cancer Inst. 1998a; 90: 1371-88., , , et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
J Clin Oncol. 1998b; 16: 441-52., , , et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.
Nat Genet. 1997; 15: 307-10., , , et al. Heterozygous ATM mutations do not contribute to early onset of breast cancer.
Arch Pathol Lab Med. 2000; 124: 966-78., , , et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
3rd Ed. Baltimore, MD: Williams & Wilkins; 1996.., , . Clinical Epidemiology - the Essentials.
Science. 2000; 287: 2017-9., , , et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids.
Oncogene. 1999; 18: 7334-42., , , , , . Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2.
Lancet. 1994; 343: 692-5., , , , . Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
[see comments]. IEEE Eng Med Biol Mag 1998; 17: 10-4.. Thermographic detection of breast cancer
Med Care. 1991; 29: 1065-82., . The effect of physician-patient communication on mammography utilization by different ethnic groups.
Health Aff (Millwood). 1999; 18: 11-21.. Health care for the elderly: how much? Who will pay for it?
Jpn J Cancer Res. 1996; 87: 1092-6., , , et al. Prospective evaluation of skin surface electro-potentials in Japanese patients with suspicious breast lesions.
Science. 1999; 285: 1359-61., , , et al. Privacy in genetics research.
[see comments] [published erratum appears in J Clin Oncol 1999 Feb; 17(2): 740]. J Clin Oncol. 1998; 16: 3105-14., . Risk-based recommendations for mammographic screening for women in their forties
Cambridge; 1999.. The Sources of Industrial Leadership, Edited by David Mowery and Richard Nelson.
Eur J Cancer. 2000; 36: 1661-70., . Clinical imaging of cancer metastasis.
New York: Oxford University Press; 1996., , , . Cost-Effectiveness in Health and Medicine.
Radiographics. 1990; 10: 1111-31., , . Highlights from the history of mammography.
Semin Nucl Med. 1999; 29: 41-8., . Breast cancer imaging with radiolabeled antibodies.
Kramer, BS; Gohagan, JK; Prorok, PC Cancer Screening: Theory and Practice. New York: M. Dekker; 1999: 13-26.. Heroic Myths and Probability: Confronting the Limits of Screening. From:
AJR Am J Roentgenol. 2000; 174: 1211-3., , , . Diagnostic radiology residents in the classes of 1999 and 2000: fellowship and employment.
Am J Manag Care . 1998; 4 Spec No:SP200-14; quiz SP215-6.. Healthcare technology assessment: methods, framework, and role in policy making.
Lancet. 2000; 355: 129-34., . Is screening for breast cancer with mammography justifiable?
Prev Med. 1992; 21: 766-80., , , . The importance of physician encouragement in breast cancer screening of older women.
New Scientist. 1999.. Closing in on cancer.
Br J Cancer. 1990; 62: 1018-22., , . Quality of life following a false positive mammogram.
J Magn Reson Imaging. 1998; 8: 1191-7., , , et al. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil.
Anticancer Res. 1999; 19: 1737-46., , , , . Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy.
Arch Pathol Lab Med. 1998; 122: 1065-76., , , , , . Providing human tissues for research: how to establish a program.
[see comments]. Nat Genet. 1996; 14: 441-7., , , , . Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis
J Med Genet. 1999; 36: 730-6., . Mutational analysis using oligonucleotide microarrays.
IEEE Trans Biomed Eng 1999 Mar; 46(3): 364]. IEEE Trans Biomed Eng. 1998; 45: 1470-9., , . Two-dimensional FDTD analysis of a pulsed microwave confocal system for breast cancer detection: fixed-focus and antenna-array sensors [published erratum appears in
BMJ. 1997; 314: 864-7., , , . Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study.
Washington Fax. 2000.. Bill to create bioimaging, bioengineering institute at NIH clears House. Advocates hope for pre-recess vote on Lott-sponsored Senate companion bill.
Proc Natl Acad Sci U S A. 1982; 79: 4672-6., , . Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture.
N Engl J Med. 1991; 325: 599-605., , . Thyroid diseases after treatment of Hodgkin's disease.
Lancet. 1998; 351: 1393-6., , , et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.
MAMM. 2000 ;3.. Services denied: why women with disabilities aren't screened for cancer.
Kramer BS, Gohagan JK, Prorok PC, eds. Cancer Screening: Theory and Practice. New York: M. Dekker; 1999: 595-609.. Genetic inheritance of cancer risk: applications to cancer screening. From:
Kramer BS, Gohagan JK, Prorok PC, eds. Cancer Screening: Theory and Practice. New York: M. Dekker; 1999: 55-75.. Decision-making about screening: individual and policy levels. From:
Proceedings of the Annual Meeting of the American Association for Cancer Research: 2000., , , et al. Bilateral Prophylactic Mastectomy (PM) in BRCA1/ 2 Mutation Carriers.
1993 ARRS President's Award [see comments]. AJR Am J Roentgenol. 1993; 161: 1167-72., , . Previous mammograms in patients with impalpable breast carcinoma: retrospective vs blinded interpretation.
1998. Edited by: Clark C. Havighurst, James F. Blumstein and Troyen A. Brennan. 2nd Edition. New York: Foundation Press, 1998.. Health care law and policy: readings, notes and questions.
[see comments]. J Natl Cancer Inst. 1996; 88: 1456-66., , , et al. Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers
Breast Cancer Res Treat. 1998; 52: 305-19., , . Assessing the clinical impact of prognostic factors: when is “statistically significant” clinically useful?
[letter; comment]. Cancer. 1997; 79: 186-8., . Thermography. Its relation to pathologic characteristics, vascularity, proliferation rate, and survival of patients with invasive ductal carcinoma of the breast
1996. 96-4159.. Investigational Device Exemptions Manual;
1995.. Interagency Agreement Between the Food and Drug Administration and the Health Care Financing Administration Regarding Medicare Coverage of Certain Investigational Medical Devices (IDE Memorandum D95-2).
Br J Radiol. 1997; 70 Spec No:S206-14., . Diagnostic imaging with light.
[see comments]. Cancer. 1998; 82: 2221-6., , . The benefits of mammography are not limited to women of ages older than 50 years
Eur J Cancer. 2000; 36: 1631-9., . Individual characterisation of the metastatic capacity of human breast carcinoma.
[see comments]. Lancet. 1999; 354: 99-105., , , et al. Early Lung Cancer Action Project: overall design and findings from baseline screening
Breast Cancer Res Treat. 1999; 58: 183-6., , , , , . Research potential of a unique xenograft model of human proliferative breast disease.
Cancer. 1999; 85: 427-31., , , et al. Predictors of local recurrence following excision alone for ductal carcinoma in situ.
Acad Radiol. 1996; 3: 351-60., , . Estimating the cost-effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model.
1998.. Uninsured in America: A Chart Book. The Kasier Commission on Medicaid and the Uninsured.
Acad Radiol. 2000; 7: 905-7., . Molecular imaging in cancer: future directions and goals of the National Cancer Institute.
[editorial]. Science. 1999; 286: 409.. Are genetic tests adequately regulated?
Acad Radiol. 2000; 7: 684-92., , , et al. Study design in the evaluation of breast cancer imaging technologies.
Radiology. 1999; 213: 39-49., , , , , . Cost-effectiveness of MR imaging and core-needle biopsy in the preoperative work-up of suspicious breast lesions.
Acad Radiol. 1999; 6: 387-97., , , . Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis.
Am J Managed Care. 2000; 6: 766-80., , . Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.
Radiol Manage. 1998; 20: 31-9.. The negative impact of MQSA (Mammography Quality Standards Act) on rural mammography programs.
M Hewitt and JV Simone, editors. Washington, D.C.: National Academy Press; 1999.. Ensuring Quality Cancer Care.
Aaron HJ, Gelband H., editors. Washington, D.C.: National Academy Press; 2000.. Extending Medicare Reimbursement in Clinical Trials.
Washington, D.C.: National Academy Press; 1996.. Mathematics and Physics of Emerging Biomedical Imaging.
Washington, D.C.: National Academy Press; 1997.. A Review of the Department of Defense's Program for Breast Cancer Research.
Washington, D.C.: National Academy Press; 1993.. Strategies for Managing the Breast Cancer Research Program: A Report to the U.S. Army Medical Research and Development Command.
Genes Chromosomes Cancer. 1999; 26: 286-94., , , et al. Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer.
Am J Surg. 1999; 177: 518-24.. Breast cancer screening.
Int J Radiat Oncol Biol Phys. 1980; 6: 681-7., , , . Microwave power absorption differences between normal and malignant tissue.
Med Phys. 1994; 21: 547-50., , , . The measured electrical properties of normal and malignant human tissues from 50 to 900 MHz.
IEEE Trans Med Imaging . 1998; 17: 1019-27.. A reappraisal of the use of infrared thermal image analysis in medicine.
Medical Devices, Obtaining FDA Market Clearence. 1995. PARAXEL International Corporation, Waltham, MA.The Framework for Regulation of Medical Devices.
JAMA. 1994; 272: 530-4., . Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States.
J Natl Cancer Inst Monogr. 1997: 79-86.. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit.
JAMA. 1993; 270: 2444-50., , , , , . Positive predictive value of screening mammography by age and family history of breast cancer.
JAMA. 1996; 276: 39-43., , , , . Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation.
JAMA. 1995; 273: 149-54., , , , . Efficacy of screening mammography. A meta-analysis.
JAMA. 1999; 282: 2156-63., , , , . Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
Naked to the Bone: Medical Imaging in the Twentieth Century. New Brunswick, NJ: Rutgers University Press; 1997..
J Am Coll Surg. 1994; 178: 491-7., , , et al. Prone scintimammography in patients with suspicion of carcinoma of the breast.
Breast Cancer Res Treat. 1999; 53: 177-83., , , , , . The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.
New Scientist. 1999.. More gain, less pain.
J Magn Reson Imaging. 1999; 10: 260-6., , , et al. Pathophysiologic basis of contrast enhancement in breast tumors.
Breast Cancer Working Group. J Womens Health. 1998; 7: 531-45., , , , . Genetic testing for BRCA1 and BRCA2: recommendations of the Stanford Program in Genomics, Ethics, and Society.
ADVANCE for Administrators in Radiology and Radiation Oncology. 2000.. Multidisciplinary breast cancer survival, part I and II.
Radiology. 1998; 207: 191-9., , . Occult cancer in women with dense breasts: detection with screening US—diagnostic yield and tumor characteristics.
Nat Med. 1998; 4: 844-7., , , et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens.
Am J Roentgenol. 1992; 158: 521-6.. The positive predictive value of mammography.
Radiology. 1996; 200: 357-60., , , et al. Positive predictive value of breast biopsy performed as a result of mammography: there is no abrupt change at age 50 years.
Med Phys. 1996; 23: 187-96., , , et al. Imaging characteristics of x-ray capillary optics in digital mammography.
inventor; Photoacoustic Breast Scanner 5713356. 1998 Feb 3.,
SPIE. 1999; 3659: 426-30., , , . Application of thermoacoustic computed tomography to breast imaging.
Radiology. 1999; 211: 275-8., , , , , . Thermoacoustic CT with radio waves: a medical imaging paradigm.
Radiology. 2000; 215: 267-79., , , et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.
J Magn Reson Imaging. 1999; 10: 159-64., , , et al. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy.
Oncogene. 1999; 18: 7644-55., . Regulation of p53 in response to DNA damage.
Science. 1980; 209: 1197-203.. Estimating cancer risks from low doses of ionizing radiation.
Cancer Detect Prev. 1996; 20: 332-41., , . Trends in mammography use and their relation to physician and other factors.
Larsen LE, Jacobi JH, Eds. Medical Applications of Microwave Imaging. Piscataway, NJ: IEEE Press; 1986.
J Natl Cancer Inst. 1998; 90: 1792-800., , , et al. Serendipity in diagnostic imaging: magnetic resonance imaging of the breast.
Can. Med. Assoc. J. 1956; 75: 309-10.. Implications of surface temperatures in the diagnosis of breast cancer.
J Natl Cancer Inst. 1996; 88: 643-9., , , . Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography.
Health Psychol. 1991; 10: 259-67., , , , , . Psychological side effects of breast cancer screening.
2001. (see http://www4.nationalacademies.org/IOM/IOMHome.nsf/Pages/Breast+Cancer+Detection)To See Today With the Eyes of Tomorrow: A History of Screening Mammography.
Diagn Imaging (San Franc). 1999; 21: 40-5.. Full-field digital mammography. A candid assessment.
Radiology 2001; 218: 873-80., , , , , , , , . Comparison of full-field digital mammography with screen-film mammography for cancer detection: results of 4945 paired examinations.
2000 Annual Meeting of the Radiological Society of North America., , , , . Clinical Evaluation of Full-Field Digital Mammography in a Screening Population.
Nature. 2000; 406: 210-5., , , et al. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response.
Nat Genet. 1997; 16: 64-7., , , et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
N Engl J Med. 2000; 343: 78-85., , , et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland.
BMJ. 1996; 312: 273-6., , , . Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial.
JAMA 2000 Apr 19;283(15): 1963]. JAMA. 1999; 282: 1061-6., , , et al. Empirical evidence of design-related bias in studies of diagnostic tests [published erratum appears in
2000; 2: 13-14., . Beyond the genome to tissue proteomics. Breast Cancer Research.
Nat Biotechnol. 2000; 18: 321-5., , , et al. In vivo visualization of gene expression using magnetic resonance imaging.
Lancet. 1996; 348: 997-9., . Breast-duct endoscopy to study stages of cancerous breast disease.
Proceedings, Era of Hope Dept. of Defense Breast Cancer Research Program Meeting. 2000 June., , , et al. Development of Intraductal Techniques for Breast Cancer Prevention, Diagnosis and Treatment.
Reading, PA: Addison-Wesley; 1995., . Dr. Susan Love's Breast Book.
Cancer. 1999; 85: 1114-8., , , . Psychologic distress in women with abnormal findings in mass mammography screening.
Cancer Res. 1998; 58: 4721-7., , , , , . Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia.
Science. 2000; 289: 1760-3., . Printing proteins as microarrays for high-throughput function determination.
Radiology. 1997; 204: 661-6., , , et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.
Radiology. 1999; 213: 866-70., , , . Near-infrared optical imaging of protease activity for tumor detection.
Health Serv Res. 1999; 34: 229-39., , . Low income, race, and the use of mammography.
Science. 1990; 250: 1233-8., , , et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
Prev Med. 1999; 28: 418-25., , , et al. Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care.
Cancer Epidemiol Biomarkers Prev. 1999; 8: 759-67., . Effectiveness of interventions designed to increase mammography use: a meta-analysis of provider-targeted strategies.
J Health Care Poor Underserved. 1995; 6: 342-51., , , , . Impact of access and social context on breast cancer stage at diagnosis.
J Natl Cancer Inst. 2000; 92: 1081-7., , , et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
Annu Rev Public Health. 1995; 16: 283-306., , . PSA screening: a public health dilemma.
Ann Clin Lab Sci. 1997; 27: 47-56., , . Current applications of molecular cytogenetic technologies.
[news]. Science. 1993; 259: 616-7.. The politics of breast cancer
Int J Cancer. 1997; 74: 443-5., , , . Soluble CD44 splice variants in metastasizing human breast cancer.
Wall Street Journal. 2000.. Screening Crunch—As more women seek mammograms, many have to wait months.
Lancet. 1992; 340: 1053-8., . Significance of CD44 gene products for cancer diagnosis and disease evaluation.
Prev Med. 1999; 28: 386-94., , , . Compliance with mammography guidelines: physician recommendation and patient adherence.
IEEE Trans Med Imaging. 1999; 18: 508-18., , , , . Nonactive antenna compensation for fixed-array microwave imaging: Part II—Imaging results.
Bethesda, MD: Medical Technology Leadership Forum; 1999.. MTLF Summit: Conditional Coverage of Investigational Technologies.
Semin Ultrasound CT MR. 2000; 21: 297-307., , . Use of Doppler ultrasound in the evaluation of breast carcinoma.
Magn Reson Imaging Clin N Am. 1994; 2: 691-703.. MR spectroscopy of the breast.
Seminars in Breast Disease. 1999; 2: 89-96.. Future directions in breast ultrasonography.
CA Cancer J Clin. 1999; 49: 138-44.. Global breast cancer mortality statistics.
Radiology. 1997; 204: 575-6., , , et al. Stereotactic breast biopsy of clustered microcalcifications with a directional, vacuum-assisted device.
Science. 1994; 266: 66-71., , , et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
2000.. Better Information, Better Outcomes? The Use of Health Technology Assessment and Clinical Effectiveness Data in the United Kingdom and the United States;
Can Med Assoc J 1993 Mar 1;148(5): 718]. CMAJ. 1992; 147: 1477-88., , , . Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years [published erratum appears in
J Natl Cancer Inst. 2000; 92: 1490-1499., , , . Canadian National Breast Screening Study-2: 13-Year Results of a Randomized Trial in Women Aged 50-59 Years.
BMJ. 2000; 321: 1071-1073., , , . Is clinical breast examination an acceptable alternative to mammographic screening?
Epithelial Cell Biol. 1995; 4: 52-62., , , , . Epidermal growth factor receptor expression on human breast luminal and basal cells in vitro.
Breast Cancer Res Treat. 1995; 36: 1-9.. When can stereotactic core biopsy replace excisional biopsy?—A clinical perspective.
J Reprod Med. 1985; 30: 451-9.. Thermography as a risk indicator of breast cancer. Results of a study and a review of the recent literature.
National Cancer Institute; 1989. Grant Number CA37970., , , . Breast Cancer Diagnosis by Lightscan (Revised) Final Report:
Kramer BS, Gohagan JK, Prorok PC, eds. Cancer Screening: Theory and Practice. New York: M. Dekker; 1999: 143-170.. Breast cancer. In:
Department of Defense Breast Cancer Research Program Meeting: June, 2000; Atlanta, GA., , , et al. Magnetic Resonance Spectroscopy Determines Pathology, Vascularisation and Node Status. Era of Hope.
Lasers Surg Med. 1995; 17: 350-7., , , , , . Spectroscopic diagnosis of bladder cancer with elastic light scattering.
Am J Prev Med. 1998; 14: 143-53., , . Estimating the accuracy of screening mammography: a meta-analysis.
Science. 1995; 269: 1854-7., , , , , . Magnetic resonance elastography by direct visualization of propagating acoustic strain waves.
Rockville, MD; 1999.. Research Involoving Human Biological Materials: Ethical Issues and Policy Guidance. Volume I, Report and Recommendations of the National Bioethics Advisory Commission.
J Natl Cancer Inst Monogr. 1997: 1-156. Proceedings. Bethesda, Maryland, USA.. National Institutes of Health Consensus Conference on Breast Cancer Screening for Women Ages 40-49.
Washington, D.C.: National Academy Press; 1999.. The Small Business Innovation Research Program: Challenges and Opportunities.
Hum Pathol. 1997; 28: 277-82., , , . Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction.
[news]. J Natl Cancer Inst. 2000; 92: 592-4.. Larger debate underlies spiral CT screening for lung cancer
J Clin Oncol. 1999; 17: 1259., , , et al. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease.
Acad Radiol. 1998 Sep; 5 Suppl 2: S310-3., . Digital mammography: a model for assessing cost-effectiveness.
Br J Cancer. 1987; 56: 814-9., , , , . Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies.
Radiology. 1997; 205: 399-406., , , et al. Digital tomosynthesis in breast imaging.
Diagn Imaging (San Franc). 1999; 21: 47-51, 75.. Computer-aided diagnosis complements full-field digital mammography.
Proc Natl Acad Sci U S A. 2000; 97: 2767-72., , , . Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement.
Proc Inst Mech Eng [H]. 1999; 213: 203-33., , , et al. Elastography: ultrasonic estimation and imaging of the elastic properties of tissues.
Recent Results Cancer Res. 1998; 152: 35-48., , , , . Experimental pathology and breast cancer genetics: new technologies.
Physiol Meas. 2000; 21: 99-109., , , , , . Multifrequency electrical impedance imaging: preliminary in vivo experience in breast.
Proc Natl Acad Sci U S A. 1999; 96: 12589-94., , , et al. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.
J Natl Cancer Inst. 1999; 91: 1113-24., , . Detection and clinical importance of micrometastatic disease.
Cancer (Phila.). 1958; 11: 377-409., , , . Exfoliative cytology of the human mammary gland and its value in the diagnosis of cancer and other diseases of the breast.
Am J Hum Genet. 1998; 62: 145-58., , . Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.
Proc Natl Acad Sci U S A. 1999; 96: 9212-7., , , et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.
Nature. 2000; 406: 747-52., , , et al. Molecular portraits of human breast tumours.
JAMA. 1999; 282: 1869-72., . Medical innovation and the critical role of health technology assessment.
Proc Natl Acad Sci U S A 1993 Mar 15; 90(6): 2556]. Proc Natl Acad Sci U S A. 1992; 89: 9064-8., , , . Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells [published erratum appears in
2000. Lancet 355: 9217-1822., , , , . UK and USA Breast Cancer Deaths Down 25% in Year 2000 at Ages 20-69 Years [Letter];
J Nucl Med. 2000; 41: 661-81.. PET: the merging of biology and imaging into molecular imaging.
Health Serv Res. 1998; 33: 29-53., , , , . Factors associated with women's adherence to mammography screening guidelines.
Rockville, MD: Physicians Insurers Association of America; 1995.. Breast Cancer Study.
Rockville, MD: Physicians Insurers Association of America; 1997.. Practice Standards Claims Survey.
Radiology. 1998a; 208: 245-9., , , , . Screening behavior of women after a false-positive mammogram.
The RDOG5 investigators. Cancer. 1998b; 82: 679-88., , , et al. Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: The Radiologic Diagnostic Oncology Group 5 Study.
Radiol Clin North Am. 2000; 38: 861-9, x., . Digital mammography, sestamibi breast scintigraphy, and positron emission tomography breast imaging.
Acad Radiol. 2000; 7: 266-80., , , et al. Current status of full-field digital mammography.
Eur. Radiology. 2000a; 10 Suppl. 3: 5430-2.. A framework for evaluating the cost-effectiveness of MRI screening for breast cancer.
Lucas Annual 2000. 2000b. Stanford, CA.. Simulation of breast cancer screening trials. Outcomes and Cost-effectiveness (Methology Development).
Phys Med Biol. 2000; 45: 1591-610., , , . Visualization and quantification of breast cancer biomechanical properties with magnetic resonance elastography.
Nat Genet. 1999; 23: 41-6., , , et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays.
Breast Cancer Res Treat. 1998; 47: 209-17.. Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention.
Med Care 1998 Oct; 36(10): 1470]. Med Care. 1998; 36: 257-70., , , . The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey [published erratum appears in
PricewaterhouseCoopers Money Tree ™ Survey, www.pwcmoneytree.com (accessed August 2000 and March 2001).
Kramer BS, Gohagan JK, Prorok PC, eds. Cancer Screening: Theory and Practice. New York: M. Dekker; 1999: 29-53., , . Screening theory and study design: the basics. From:
Cancer Epidemiol Biomarkers Prev. 1999; 8: 985-90., , , et al. Elevation of serum riboflavin carrier protein in breast cancer.
3rd, , . Mandated coverage for cancer-screening services: whose guidelines do states follow? Am J Prev Med. 2000; 19: 71-8.,
Santa Monica, CA: RAND; 1997.. Health Care in Transition: Technology Assessment in the Private Sector.
J Natl Cancer Inst. 2000; 92: 184-6.. Gene patent race speeds ahead amid controversy, concern.
Bethesda, MD; 1999., , . SEER Cancer Statistic Review, 1973-1996.
Radiology. 1989; 172: 243-6., , , , . Why women resist screening mammography: patient-related barriers.
Am J Roentgenol. 1996; 167: 1415-9., , , et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology.
Radiology. 1998; 209: 269-75., , , . Human breast lesions: characterization with proton MR spectroscopy.
Pathol Annu. 1981; 16: 337-56.. Clinical implications of preinvasive and small invasive breast carcinomas.
Cancer. 1980; 46: 919-25., , . The clinical significance of pre-invasive breast carcinoma.
Anal Chem. 1975; 47: 592-602.. Photoacoustic spectroscopy.
Cancer. 1998; 82: 2235-40., . Screening mammography beginning at age 40 years: a reappraisal of cost-effectiveness.
Science. 1997; 275: 1755-7., , , et al. Genetic information and the workplace: legislative approaches and policy changes.
Am J Surg. 1997; 174: 694-6; discussion 697-8., , , et al. Use of fine needle aspiration for solid breast lesions is accurate and cost-effective.
Environ Health Perspect. 1996; 104: 938-67., . Mammary gland neoplasia in long-term rodent studies.
The Mammary Gland. 1987: 67-105. Plenum: New York., , Development of human mammary gland.
ASAIO J. 2000; 46: 29-30.. The conduct of clinical trials: a Food and Drug Agency perspective.
Br J Cancer. 1999; 81: 1222-7., , , et al. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size.
Br J Cancer. 1997; 76: 494-501., , , et al. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk.
J Steroid Biochem Mol Biol. 1999; 71: 21-7., , , . Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility.
Eur J Nucl Med. 1999; 26: 1279-88., , , , , . High-resolution scintimammography improves the accuracy of technetium-99m methoxyisobutylisonitrile scintimammography: use of a new dedicated gamma camera.
Surg Clin North Am. 1999; 79: 991-1005., . Breast cancer. Making the diagnosis.
Russia/St. Petersburg/WHO). Vopr Onkol. 1999; 45: 265-71., , , et al. Interim results of a prospective randomized study of self-examination for early detection of breast cancer (
(results of the 5-years USSR/WHO randomized study in Leningrad). Eur J Epidemiol. 1992; 8: 498-502., , , et al. The role of breast self-examination in early breast cancer detection
Science. 2000; 289: 1673.. Biochemistry. Protein arrays step out of DNA's shadow.
Genes Chromosomes Cancer. 2000; 27: 124-9., , , et al. Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor.
July 1997).“Report of the Secretary to the President: Health insurance in the age of genetics.” (
J Natl Cancer Inst Monogr. 1997: 27-30.. Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan.
Nature. 1997; 386: 804-10., , , et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2.
Br J Cancer. 1998; 78: 922-7., , , et al. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients.
Cancer Res. 1992; 52: 2984-6., , , et al. Inherited p53 gene mutations in breast cancer.
JAMA. 1996; 276: 1339-41., , , . Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.
Oncology (Huntingt). 1997; 11: 393-406, 409-10; discussion 413-5., . Use of predictors of recurrence to plan therapy for DCIS of the breast.
Phys Med Biol. 2000; 45: 1649-64., , , , , . High-resolution tensor MR elastography for breast tumour detection.
Surg Clin North Am. 1999; 79: 961-90., . Breast cancer screening.
Diagn Cytopathol. 1996; 14: 385-9., , , . Malpractice protection: communication of diagnostic uncertainty.
Am J Med. 2000; 108: 112-9., , , . Is screening mammography effective in elderly women?
1981; 41: 4637-43., , , , . Clonal proliferation of cultured nonmalignant and malignant human breast epithelia.
Seminars in Breast Disease. 1999; 2: 280-91.. Risk-Based Screening For Breast Cancer: Is There a Practical Strategy?
1991; 1.. A comparison of fine needle aspiration, core biopsy, and needle localization biopsy techniques in mammographically detectable nonpalpable breast lesions.
2001.. President Clinton signs bill to create NIH Institute of Biomedical Imaging and Bioengineering: NIH effort to build Office of Bioengineering, Bioimaging and Bioinformatics effectively derailed.
Radiology. 1995; 196: 123-34., , , , , . Solid breast nodules: use of sonography to distinguish between benign and malignant lesions.
[news]. Science. 2000; 287: 1575.. Magnetic resonance imaging. Detecting enzyme activity in live animals
Issue Brief Natl Health Policy Forum. 1998: 1-8.. Medicare coverage and technology diffusion: past, present, and future.
N Engl J Med. 1997; 336: 1401-8., , , et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
Seminars In Breast Disease. 1999; 2: 97-106., , , , . Scintimammography.
Radiology. 1999; 210: 345-51., , , , . Mammography in the 1990s: the United States and Canada.
N Engl J Med. 1991; 325: 1831-6., , , . Incidence of cancer in 161 families affected by ataxia-telangiectasia.
Surg Oncol Clin N Am. 2000; 9: 233-77., , , , . A new era in the diagnosis of breast cancer.
Cancer. 1999; 86: 449-62., , , , . The natural history of breast carcinoma: what have we learned from screening?
1999; 22: 414-8., , , , . Role of magnetic resonance imaging and magnetic resonance imaging—guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol.
Nat Genet. 1996; 12: 333-7., , , et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.
Freshney RI, Editor); Culture of Human Mammary Epithelial Cells. Culture of Epithelial Cells. Wiley-Liss, USA; 1992: 107-33., (
1999; 1.. Outlook For Medical Technology Innovation. Will Patients Get The Care They Need?
2000; 2.. Outlook For Medical Technology Innovation. Will Patients Get The Care They Need?
J Natl Cancer Inst. 1997; 89: 355-65., , , et al. Randomized trial of breast self-examination in Shanghai: methodology and preliminary results.
Ann N Y Acad Sci 1998 Feb 9; 838: 171-93., . Physiological and pathological factors of human breast disease that can influence optical diagnosis.
Radiology. 1994; 191: 241-4., , . Benefit of independent double reading in a population-based mammography screening program.
Acta Radiol. 1998; 39: 384-8., , , . Sensitivity and specificity of computer-assisted breast cancer detection in mammography screening.
J Steroid Biochem Mol Biol. 1997; 62: 119-28., . The role of estrogen receptor mutations in tamoxifen-stimulated breast cancer.
OTA-H-608 ( Washington, D.C., U.S. Government Printing Office, September, 1994).. “Identifying Health Technologies that Work: Searching for Evidence.”
Department of Health and Human Services; 2000.. Health, United States, 2000. With Adolescent Health Chartbook:
1998a. GAO/HEHS98-164.. Mammography Quality Standards Act: X-Ray Quality Improved, Access Unaffected, but Impact on Health Outcomes Unknown;
1998b. GAO/HEHS-98-11.. Mammography Services: Impact of Federal Legislation on Quality, Access, and Health Outcomes;
Guide to Clinical Preventive Services. 2nd ed. Baltimore MD: Williams & Wilkins; 1996: 73-88. HealthSTAR., Screening for breast cancer. In:.
Int J Cancer. 1996; 66: 727-31., , , et al. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality.
Cancer. 1993; 72: 1933-8., , , . The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers.
Ann Surg. 1999; 229: 625-30; discussion 630-3., , , et al. Comparison of mammographically guided breast biopsy techniques.
Soc Sci Med. 1990; 30: 1107-18., , . Participation in breast screening programs: a review.
Arch Surg. 1996; 131: 967-72; discussion 972-4., , , , . Diagnosis of palpable breast lesions in younger women by the modified triple test is accurate and cost-effective.
Diagn Imaging (San Franc). 1999; 21: 33-4, 62.. Verdict on MQSA: quality up, but so is financial burden.
Radiology 2000 Jul; 216(1): 306]. Radiology. 2000; 215: 554-62., , , et al. Potential contribution of computer-aided detection to the sensitivity of screening mammography [published erratum appears in
Dentomaxillofac Radiol. 1997; 26: 53-62., , , . Tuned-aperture computed tomography (TACT). Theory and application for three-dimensional dento-alveolar imaging.
Curr Opin Obstet Gynecol. 1995; 7: 4-9.. Prognostic factors in breast carcinoma.
J Natl Cancer Inst. 1992; 84: 1875-87., , , et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.
Ann Intern Med. 1997; 127: 1023-8., . Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find?
Trends Genet. 2000; 16: 69-74., , . Insights into the functions of BRCA1 and BRCA2.
Cellular and Molecular Biology of Mammary Cancer. 1987: 163-79., , , , . Rodent models to examine in vivo hormonal regulation of mammary gland tumorigenesis.
Ultrason Imaging. 1999; 21: 186-200.. Volumetric Hall effect tomography—a feasibility study.
IEEE Trans Biomed Eng. 1998; 45: 119-24., , . Hall effect imaging.
J Natl Cancer Inst. 1998; 90: 906-10., , , et al. Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years.
Public Health Paper (No. 34). Geneva, World Health Organization. 1968; 26., . Principles and practice of screening for disease.
Kramer EJ, Ivey SL, Ying Y-W, Editors); Breast and Cervical Cancer. Immigrant Women's Health, Problems and Solutions. San Francisco, CA: Jossey-Bass Publishers; 1999.(
Adv Anat Pathol. 2000; 7: 26-35., , Recent developments in stereotactic breast biopsy methodologies: an update for the surgical pathologist.
Nature 1996 Feb 22; 379(6567): 749]. Nature. 1995; 378: 789-92., , , et al. Identification of the breast cancer susceptibility gene BRCA2 [published erratum appears in
Am J Epidemiol. 1992; 135: 130-41., , , et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid.
Lifetime Data Anal. 1998; 4: 169-86., , . Estimating lifetime and age-conditional probabilities of developing cancer.
Cancer Epidemiol Biomarkers Prev. 1999; 8: 749-57., . Interventions targeted toward patients to increase mammography use.
Science. 2000; 289: 1890-2., , . Tech.sight. Genetic testing—present and future.
Clin Cancer Res. 2000; 6: 1432-8., , , , , . CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer.
Surg Oncol Clin N Am. 1999; 8: 17-33., , . The difficult breast.